These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36016208)

  • 1. Estimates of the Global Burden of COVID-19 and the Value of Broad and Equitable Access to COVID-19 Vaccines.
    Bell E; Brassel S; Oliver E; Schirrmacher H; Arnetorp S; Berg K; Darroch-Thompson D; Pohja-Hutchison P; Mungall B; Carroll S; Postma M; Steuten L
    Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study.
    Watson OJ; Barnsley G; Toor J; Hogan AB; Winskill P; Ghani AC
    Lancet Infect Dis; 2022 Sep; 22(9):1293-1302. PubMed ID: 35753318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis.
    So AD; Woo J
    BMJ; 2020 Dec; 371():m4750. PubMed ID: 33323376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVAX and equitable access to COVID-19 vaccines.
    Yoo KJ; Mehta A; Mak J; Bishai D; Chansa C; Patenaude B
    Bull World Health Organ; 2022 May; 100(5):315-328. PubMed ID: 35521037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of delayed access to COVID-19 vaccines in low- and lower-middle-income countries.
    Duroseau B; Kipshidze N; Limaye RJ
    Front Public Health; 2022; 10():1087138. PubMed ID: 36711400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inequities in the deployment of COVID-19 vaccine in the WHO Eastern Mediterranean Region, 2020-2021.
    Hasan Q; Elfakki E; Fahmy K; Mere O; Ghoniem A; Langar H; Musa N; Attia R; Othman MM; Samhouri D; Chaudhri I; Abubakar A; Hajjeh R; Hutin YJ
    BMJ Glob Health; 2022 Jun; 7(Suppl 4):. PubMed ID: 35764354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The health and economic burden of smoking in 12 Latin American countries and the potential effect of increasing tobacco taxes: an economic modelling study.
    Pichon-Riviere A; Alcaraz A; Palacios A; Rodríguez B; Reynales-Shigematsu LM; Pinto M; Castillo-Riquelme M; Peña Torres E; Osorio DI; Huayanay L; Loza Munarriz C; de Miera-Juárez BS; Gallegos-Rivero V; De La Puente C; Del Pilar Navia-Bueno M; Caporale J; Roberti J; Virgilio SA; Augustovski F; Bardach A
    Lancet Glob Health; 2020 Oct; 8(10):e1282-e1294. PubMed ID: 32971051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 Vaccines: How Efficient and Equitable Was the Initial Vaccination Process?
    Das JK; Chee HY; Lakhani S; Khan MH; Islam M; Muhammad S; Bhutta ZA
    Vaccines (Basel); 2022 Dec; 11(1):. PubMed ID: 36679856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global diversity of policy, coverage, and demand of COVID-19 vaccines: a descriptive study.
    Chen Z; Zheng W; Wu Q; Chen X; Peng C; Tian Y; Sun R; Dong J; Wang M; Zhou X; Zhao Z; Zhong G; Yan X; Liu N; Hao F; Zhao S; Zhuang T; Yang J; Azman AS; Yu H
    BMC Med; 2022 Apr; 20(1):130. PubMed ID: 35369871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimated global public health and economic impact of COVID-19 vaccines in the pre-omicron era using real-world empirical data.
    Yang J; Vaghela S; Yarnoff B; De Boisvilliers S; Di Fusco M; Wiemken TL; Kyaw MH; McLaughlin JM; Nguyen JL
    Expert Rev Vaccines; 2023; 22(1):54-65. PubMed ID: 36527724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic Benefits of Immunization for 10 Pathogens in 94 Low- and Middle-Income Countries From 2011 to 2030 Using Cost-of-Illness and Value-of-Statistical-Life Approaches.
    Watts E; Sim SY; Constenla D; Sriudomporn S; Brenzel L; Patenaude B
    Value Health; 2021 Jan; 24(1):78-85. PubMed ID: 33431157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: a systematic review.
    Ozawa S; Mirelman A; Stack ML; Walker DG; Levine OS
    Vaccine; 2012 Dec; 31(1):96-108. PubMed ID: 23142307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Head and neck cancer in South Asia: macroeconomic consequences and the role of surgery.
    Alkire BC; Bergmark RW; Chambers K; Cheney ML; Meara JG
    Lancet; 2015 Apr; 385 Suppl 2():S56. PubMed ID: 26313106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global economic consequences of selected surgical diseases: a modelling study.
    Alkire BC; Shrime MG; Dare AJ; Vincent JR; Meara JG
    Lancet Glob Health; 2015 Apr; 3 Suppl 2(Suppl 2):S21-7. PubMed ID: 25926317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimated economic impact of vaccinations in 73 low- and middle-income countries, 2001-2020.
    Ozawa S; Clark S; Portnoy A; Grewal S; Stack ML; Sinha A; Mirelman A; Franklin H; Friberg IK; Tam Y; Walker N; Clark A; Ferrari M; Suraratdecha C; Sweet S; Goldie SJ; Garske T; Li M; Hansen PM; Johnson HL; Walker D
    Bull World Health Organ; 2017 Sep; 95(9):629-638. PubMed ID: 28867843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Access to COVID-19 vaccines and testing in Africa: the importance of COVAX - Nigeria as a case study.
    Grenfell RFQ; Oyeyemi OT
    Pathog Glob Health; 2023 Mar; 117(2):152-166. PubMed ID: 35770309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the global burden of endemic canine rabies.
    Hampson K; Coudeville L; Lembo T; Sambo M; Kieffer A; Attlan M; Barrat J; Blanton JD; Briggs DJ; Cleaveland S; Costa P; Freuling CM; Hiby E; Knopf L; Leanes F; Meslin FX; Metlin A; Miranda ME; Müller T; Nel LH; Recuenco S; Rupprecht CE; Schumacher C; Taylor L; Vigilato MA; Zinsstag J; Dushoff J;
    PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003709. PubMed ID: 25881058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitigating donor interests in the case of COVID-19 vaccine: the implication of COVAX and DAC membership.
    Fang Y; Ma T; Wu M; Tsuei SH
    BMJ Glob Health; 2023 Jan; 8(1):. PubMed ID: 36642442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investing in late-stage clinical trials and manufacturing of product candidates for five major infectious diseases: a modelling study of the benefits and costs of investment in three middle-income countries.
    Schäferhoff M; Zimmerman A; Diab MM; Mao W; Chowdhary V; Gill D; Karanja R; Madikizela M; Ogbuoji O; Yamey G
    Lancet Glob Health; 2022 Jul; 10(7):e1045-e1052. PubMed ID: 35714631
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.